Scarica l'app Stockscreener
43.85
2.58%
-1.185
Medline Inc Borsa (MDLN) Ultime notizie
Is It Too Late To Consider Medline (MDLN) After Its Recent Share Price Rally? - Yahoo Finance
Medline stock pops 40% in first trading session after company raises $6.3 billion in 2025's biggest IPO - AOL.com
Evaluating Medline (MDLN) After Recent Share Price Momentum And A 31.1x P/E Multiple - Sahm
Medline Inc. (MDLN) Stock Price | Live Quotes & Charts | NASDAQ - StocksToTrade
Medline Inc.Class A common stock (NQ: MDLN - FinancialContent
MDLN Medline Inc. Feb 2026 Tigress Financial Initiates Coverage with Buy - Meyka
Tigress Financial initiates Medline stock with Buy rating, $55 target By Investing.com - Investing.com Nigeria
Tigress Financial initiates Medline stock with Buy rating, $55 target - Investing.com
Jim Boyle: 100 Most Influential People in Healthcare 2025 - Modern Healthcare News
Medline (NASDAQ:MDLN) Now Covered by Analysts at Tigress Financial - MarketBeat
Tigress Initiates Medline at Buy With $55 Price Target - marketscreener.com
How the Largest IPO of 2025 Could Be Healthy for Your Portfolio - The Motley Fool
Wash. Justices Won't Hear Medline's $2.4M Refund Request - Law360
Medline CEO Jim Boyle talks record IPO and AI plans with hospitals - Crain's Chicago Business
Medline’s Jim Boyle talks record IPO, AI plans with hospitals - Modern Healthcare News
Medline to report fourth quarter and full year 2025 results on February 25, 2026 - GlobeNewswire
Is It Time To Reassess Medline (MDLN) After Its Recent Share Price Climb - Yahoo Finance
Medline Inc (MDLN) Shares Up 3.65% on Jan 22 - GuruFocus
Jim Cramer says Medline stock is unbelievable and recommends buying it - MSN
Jim Cramer Says Medline "Stock Is Unbelievable" And Recommends Buying It - Finviz
Jim Cramer Says Medline “Stock Is Unbelievable” And Recommends Buying It - Yahoo Finance
Medline Industries: Solid Physical Moat With Visible Earnings Growth Runway (NASDAQ:MDLN) - Seeking Alpha
Jim Cramer Recently Looked at These 25 Stocks - Insider Monkey
Is There An Opportunity In Medline (MDLN) After Recent DCF Valuation Results - Sahm
Pointcore Supply Chain Services members select Medline as distributor - Medline Newsroom
Ranpak expands packaging automation partnership with Medline - Packaging Insights
In face of uncertainty and tariffs, newly public Medline sticks to the old formula - Crain's Chicago Business
Ranpak and Medline deepen packaging automation collaboration - Yahoo Finance
Ranpak in Collaboration with Medline - Medical Device and Diagnostic industry
Medline Shares Climb as Analysts Launch Coverage After $7.2 Bill - GuruFocus
Medline Shares Climb as Analysts Launch Coverage After $7.2 Billion IPO - Yahoo Finance
Ranpak and Medline Partner to for High-Volume Distribution Operations From: Ranpak Corporation - Healthcare Packaging
Ranpak Holdings Corp. and Medline Partner to Advance Automation and Sustainable Packaging Across High-Volume Distribution Operations - marketscreener.com
Ranpak and Medline Partner to Advance Automation and Sustainable Packaging Across High-Volume Distribution Operations - Business Wire
Analysts Are Bullish on These Healthcare Stocks: Exagen (XGN), Medline, Inc. Class A (MDLN) - The Globe and Mail
Analysts Offer Insights on Healthcare Companies: Medline, Inc. Class A (MDLN) and IDEAYA Biosciences (IDYA) - The Globe and Mail
Medline jumps as analysts bullish after 2025’s top IPO - The Daily Gazette
Medline Jumps as Analysts Bullish After 2025’s Top IPO - Bloomberg
Analysts initiate coverage on Medline after IPO, flag growth visibility and margin - Investing.com
Why Is Medline Stock Gaining Monday?Medline (NASDAQ:MDLN) - Benzinga
Analysts Say Medline Has The Secret Sauce For Sustained Growth - Sahm
Is Medline (MDLN) Fairly Priced After Recent Share Price Stability? - Yahoo Finance
Analysts initiate Medline with bullish ratings after blockbuster IPO - Reuters
TD Cowen initiates Medline stock with Buy rating on market share growth - Investing.com Nigeria
BTIG initiates coverage on Medline stock with Buy rating, $50 target By Investing.com - Investing.com South Africa
Wells Fargo & Company Begins Coverage on Medline (NASDAQ:MDLN) - MarketBeat
This Netflix Begins Coverage On A Bullish Note; Here Are Top 5 Initiations For Monday - Benzinga
Medline initiated with a Buy at BTIG - TipRanks
Goldman Sachs Initiates Coverage on Medline With Buy Rating, $49 Price Target - marketscreener.com
BMO Capital Initiates Coverage on Medline With Outperform Rating, $45 Price Target - marketscreener.com
JPMorgan Initiates Coverage on Medline With Overweight Rating, $50 Price Target - marketscreener.com
William Blair initiates Medline stock with Outperform rating By Investing.com - Investing.com South Africa
BTIG initiates coverage on Medline stock with Buy rating, $50 target - Investing.com Nigeria
Wells Fargo initiates coverage on Medline stock with Equal Weight rating - Investing.com Nigeria
BofA Securities initiates Medline stock with Buy rating, $50 price target - Investing.com Nigeria
Analysts initiate Medline with bullish ratings after blockbuster IPO By Reuters - Investing.com
4.63%
Apri su Yahoo
|
Apri su Google
|
Aperto in Finviz
|
Apri in MarketWatch
|
Aperto a EDGAR
|
Aperto su Reuters
Capitalizzazione:
|
Volume (24 ore):